Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2019
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant ResearchDavid Buchbinder, Ruta Brazauskas, Khalid Bo-Subait, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid MalignanciesMarcelo C Pasquini, Mei-Jie Zhang, Bruno C Medeiros, et al.
Transplantation and Cellular Therapy|October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research StudyNelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Blood Advances|May 5, 2019
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemiaRohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Blood Advances|May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysisRoni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2020
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCTRohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic SyndromesAziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Transplantation and Cellular Therapy|April 25, 2021
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S Bhatt, Ruta Brazauskas, Rachel B Salit, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantationMehdi Hamadani, Parameswaran N Hari, Ying Zhang, et al.
Pageof 11